What is ARTL's dilution risk score?

ARTL has a latest available DilutionScore record of 88/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ARTL, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ARTL?

DilutionWatch tracks 25 SEC filing types for ARTL including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ARTL shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ARTL, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ARTL tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ARTL. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ARTL Dilution Risk Score: 88/100 (CRITICAL)

Score Breakdown

📋 Offering Ability

100

💰 Cash Runway

65

📊 Float Risk

60

⚠️ Warrant Exposure

90

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 48%

📜 Warrant Exercise model 60%

• Massive warrant overhang: 220% of shares outstanding

• Warrant risk score very high (90/100)

💰 Capital Raise model 53%

• Under 12 months cash (6mo)

• Active shelf registration ($75M, 1537% of market cap)

📉 Score Deterioration model 15%

• Score already CRITICAL (88/100) — events likely imminent

🔔 Track ARTL — Get forecast alerts →

Market Data

Market Cap$4.88M

Shares Outstanding4.60M

Float2.12M

Cash$4.20M

Debt$719.0K

Short InterestN/A

Institutional Holdings

QoQ: ↓ 98.0% shares (2026Q1 vs prior)

2 institutional holders · 2.0K shares

#1 MORGAN STANLEY 1.1K shares

#2 Altshuler Shaham Ltd 889 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest135.1K

Days to Cover1.0

% of Float6.4%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-06-30

xbrl XBRL WARRANT 2026-03-31

S-3 SHELF 2026-05-04

424B3 ATM 2026-04-16

EFFECT EFFECT 2026-04-15

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ARTL Dilution Snapshot

Artelo Biosciences, Inc. (ARTL) has a DilutionScore of 88/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $75.0M.
Stored ATM program remaining capacity: $31.4M.
Stored outstanding warrants: 10.1M.
Recent SEC activity tracked for ARTL: xbrl on 2026-06-30; S-3 on 2026-05-04; 424B3 on 2026-04-16.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.